Travere Therapeutics Inc (TVTX)

NASDAQ · Biotechnology

63.32
-0.21 (-0.33%)
Updated Aug 18, 5:55 PM ET
AI Rating
Buy
Overall Score
74
Trend
75
Momentum
84
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 23, 2026 120 sessions Aug 14, 2026

AI Analysis

Travere Therapeutics Inc is trading at $63.32, down 0.33% on the session. The 50 day average sits at $55.90 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 62.6, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $60.20 with resistance near $66.24, so that band frames the current range. Average daily movement is roughly $2.79, or about 4.4% of the share price, which is what any stop placement has to allow for. The overall health score of 74 out of 100 combines a trend score of 75, momentum of 84 and a risk score of 58.

Technical indicators

RSI (14)
62.6
strong
MACD
1.814
bullish crossover
SMA 20
58.44
SMA 50
55.90
SMA 200
--
unknown
ATR (14)
2.79
avg daily range
Support
60.20
Resistance
66.24
Volume vs 20d
0.71x
below average
Volatility
50.4%
annualised
1 month
+9.52%
3 months
+39.48%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.